Peptides for hair growth: what works?
A few small studies look hopeful. Approved hair loss medicines have much more proof.
By the Peptide Science Desk Editorial TeamFact-checked against FDA and official sources · Not yet reviewed by a licensed clinician. How we check facts

Do peptides help hair growth?
- No peptide is FDA approved to treat hair loss.
- We found only a few small studies in people. Each one tested a different peptide product, for 4 to 6 months.
- Some found more hairs, or thicker hairs, than a fake treatment (placebo). None was big enough to prove it works.
- Whether a peptide works, whether it is safe, and whether it is FDA approved are 3 separate questions. We rate each one on its own.
Is GHK-Cu good for hair growth?
- GHK-Cu is a tiny peptide joined with copper. It is sold in creams, serums, and shots.
- In one 6-month study of 45 men with male pattern hair loss, a lotion with GHK (the peptide part) plus another ingredient (5-ALA) grew more hairs than a fake lotion. Hair length and thickness did not change more than with the fake lotion.
- The lotion mixed 2 ingredients, so nobody can tell if GHK did the work.
- A 2026 review of GHK-Cu studies said proof in people is "thin." Most human trials were small and tested face creams. About 1 in 3 GHK-Cu studies included authors with business ties to it.
- We found no published study of GHK-Cu shots for hair in people.
Can peptides cause hair loss?
- Some approved peptide drugs list hair loss as a side effect. Their FDA labels say it was linked to weight loss.
- Zepbound (tirzepatide): in 2 big trials, 7.1% of women and 0.5% of men on the drug reported hair loss. On placebo, it was 1.3% of women and 0% of men.
- Wegovy (semaglutide): in its weight trials, 3.3% of people on the drug reported hair loss, vs 1% on placebo.
- The Ozempic and Mounjaro labels also list hair loss in reports from after approval.
- For most unapproved peptides, too few people were studied to know. Unknown is not the same as safe.
- If you lose hair on any medicine, tell your doctor. Do not stop a prescribed medicine on your own.
Peptides for hair loss: what is FDA approved?
- None of these are peptides. But they are the options with the most proof.
- Minoxidil (Rogaine): sold without a prescription, as a liquid or foam for the top of the scalp. There are versions for men and for women. The men’s label says some men need at least 4 months to see results, and it does not work for everyone.
- Finasteride (Propecia): a prescription pill for male pattern hair loss, for men only. The FDA label is based on 3 one-year trials with 1,879 men. Women who are or may become pregnant must not use it.
- Baricitinib (Olumiant): a prescription pill the FDA approved in 2022 for severe alopecia areata. That is an illness where the body attacks hair roots and hair falls out in patches.
- Ask a doctor which one fits your type of hair loss.
Peptides for hair growth: men vs women
- Men: a GHK lotion study (45 men) and a 5-amino-acid peptide lotion study (22 men in Japan) looked at male pattern hair loss. Both were small.
- Women: a 24-week trial of 114 women with thinning hair tested a collagen peptide supplement. Hair got a little thicker than with placebo. It measured how thick each hair was, not how many hairs grew.
- Finasteride is not for women. Minoxidil has a women’s version.
- A doctor can look for the cause of hair loss before you try any product.
Do oral peptides for hair growth work?
- Most "oral peptides for hair" are collagen peptide supplements. They are sold as supplements, not drugs.
- By law, the FDA does not approve supplements before they are sold.
- One 2026 trial in 114 women found thicker hair after 24 weeks on a collagen peptide product. Some of the authors work for the company that makes it.
- One study is not enough to prove a supplement works.
Are peptide injections for hair growth safe?
- Nobody knows. We found no published study of peptide shots for hair in people.
- GHK-Cu shots are not FDA approved. The FDA says there is very little safety data on them.
- Any shot that is not made clean can cause harm. The FDA says contaminated or poor-quality compounded drugs can cause serious injury or death.
- The FDA says products sold "for research" are of unknown quality and may be harmful.
- "Not FDA approved" does not always mean illegal. The rules depend on the product and how it is made and sold.
The numbers in charts
Hair treatments: how many people were tested
People in the main trial we cite for each one (log scale, so small studies still show)
Finasteride pillFDA approvedMen with hair loss · not a peptide
Baricitinib pill (BRAVE-AA1 + AA2)FDA approvedAlopecia areata · not a peptide · about 36–39% of people on 4 mg hit the hair goal vs 3–6% on placebo
Collagen peptide drinkNot FDA approvedWomen with thinning hair
GHK copper peptide + 5-ALA lotionNot FDA approvedMen
Pentapeptide lotionNot FDA approvedMen
The FDA-approved hair drugs were tested in far more people than any peptide.
Show the numbers as a table
| Treatment | People |
|---|---|
| Finasteride pill (FDA approved) Men with hair loss · not a peptide | 1,879 |
| Baricitinib pill (BRAVE-AA1 + AA2) (FDA approved) Alopecia areata · not a peptide · about 36–39% of people on 4 mg hit the hair goal vs 3–6% on placebo | 1,200 |
| Collagen peptide drink (Not FDA approved) Women with thinning hair | 114 |
| GHK copper peptide + 5-ALA lotion (Not FDA approved) Men | 45 |
| Pentapeptide lotion (Not FDA approved) Men | 22 |
Hair loss on GLP-1 shots
% of adults with hair loss in the weight-loss trials, drug vs placebo
Wegovy 2.4 mg (semaglutide)FDA label, weight-loss trials
Wegovy 7.2 mg (semaglutide)FDA label, 7.2 mg trial
Zepbound 5, 10 or 15 mg (tirzepatide)FDA label · 4% to 5% across doses
Most people did not lose hair. It was more common than on placebo.
Show the numbers as a table
| Trial | Drug | Placebo |
|---|---|---|
| Wegovy 2.4 mg (semaglutide) FDA label, weight-loss trials | 3.3% | 1.0% |
| Wegovy 7.2 mg (semaglutide) FDA label, 7.2 mg trial | 5.8% | 1.0% |
| Zepbound 5, 10 or 15 mg (tirzepatide) FDA label · 4% to 5% across doses | 4–5% | 1% |
Hair loss was more common in women
% with hair loss on the drug, women vs men (FDA labels)
Wegovy 2.4 mgPlacebo: women 2%, men 0%
Wegovy 7.2 mgPlacebo: women 1.5%, men 0%
Zepbound (all doses)Placebo: women 1.3%, men 0%
Women had hair loss much more often than men on both drugs.
Show the numbers as a table
| Trial | Women | Men |
|---|---|---|
| Wegovy 2.4 mg Placebo: women 2%, men 0% | 4% | 0.9% |
| Wegovy 7.2 mg Placebo: women 1.5%, men 0% | 8.4% | 0.2% |
| Zepbound (all doses) Placebo: women 1.3%, men 0% | 7.1% | 0.5% |
What studies in people show
| Study type | People | Main finding | Limits |
|---|---|---|---|
| Randomized, placebo-controlled, 6 months: GHK + 5-ALA lotion | 45 men | More new hairs than placebo. No difference in hair length or thickness. No side effects reported. | Small. Mixed 2 ingredients, so the effect of GHK alone is unknown. |
| Randomized, double-blind, 4 months: 5-amino-acid peptide lotion (GPIGS) | 22 men | More thick hairs and better-looking scalp photos than placebo. No skin side effects noted. | Very small. Run by a cosmetics company. Not a medicine you can get. |
| Randomized, placebo-controlled, 24 weeks: collagen peptide supplement | 114 women | Hair got thicker (wider) than with placebo. | Measured hair thickness, not number of hairs. Some authors work for the maker. |
| Review of GHK-Cu studies (2026) | 64 studies reviewed | Most proof is from cells and animals. Human trials are few, small, and mostly face creams. | About 1 in 3 GHK-Cu studies share authors with business ties. |
| Three 1-year placebo-controlled trials: finasteride (not a peptide, FDA approved) | 1,879 men | The FDA reviewed these trials and approved it for male pattern hair loss. | Men only. Sexual side effects: 3.8% on the drug vs 2.1% on placebo. |
| Two big placebo-controlled trials: baricitinib (not a peptide, FDA approved) | 1,200 adults | At 36 weeks, about 36% to 39% on the higher dose had 80% or more of their scalp hair, vs 3% to 6% on placebo. | Only for severe alopecia areata, not common balding. Side effects included acne and higher cholesterol. |
Hair options at a glance
| Minoxidil (Rogaine) | Finasteride (Propecia) | GHK-Cu lotions | Collagen peptide pills | Peptide shots | |
|---|---|---|---|---|---|
| FDA status for hair | Approved (no prescription needed) | Approved (prescription, men only) | Not approved | Supplement (FDA does not approve these) | Not approved |
| Proof it works in people | Enough for FDA approval. The label says it does not work for everyone. | 3 one-year trials, 1,879 men | Early: 1 small study, mixed with another ingredient | Early: 1 trial, measured hair thickness | None found |
| Safety data in people | Well studied (on FDA label) | Well studied (on FDA label) | Very little | Limited | Very little |
FAQ
Can I use a peptide serum with minoxidil?
Ask your doctor or pharmacist first. The men’s minoxidil label says not to use it if you use other medicines on your scalp.
How long should I try a hair product before I judge it?
The hair studies above lasted 4 to 12 months. Hair grows slowly, so a few weeks is too soon to tell.
Are Reddit "before and after" hair photos proof?
No. Photos can differ in light, angle, and haircut. People often start several things at once. Trials with a placebo group are the fair test.
Do collagen peptides help hair, skin, and nails?
One 2026 trial found slightly thicker hair in women. We did not review nail studies. Supplements are not checked by the FDA before they are sold.
Who should I see about hair loss?
A doctor, often a skin doctor (dermatologist). They can look for the cause and talk about approved options.
Is GHK-Cu the same as "copper peptide" on skin care labels?
Usually, yes. Labels may also say "copper tripeptide-1." A cream is not the same as a shot, and creams were studied more.
Related pages
- GLP-1: Wegovy / Ozempic (semaglutide)FDA approved · Proof: Strong
- GLP-1: Zepbound / Mounjaro (tirzepatide)FDA approved · Proof: Strong
- GHK-CuNot approved · Proof: Early
- Are collagen peptides the same as peptides?Guide
- Peptide side effects: what is common and what is serious?Guide
- GLP-1 hair loss: how common is it, and does it grow back?Guide
- Do peptides really work? The honest answerGuide
- Are Peptides Safe? What to Know FirstGuide
- Peptides vs GLP-1: what's the difference?Guide
- Peptide side effects checkerTool
- Is there a peptide for my goal?Tool
- Compare GLP-1: Wegovy / Ozempic vs GLP-1: Zepbound / MounjaroComparison tool
We never share doses or tell you where to buy. Always ask your doctor. Print our doctor questions sheet.
Sources
- PubMed: Lee et al., Efficacy of a complex of 5-aminolevulinic acid and GHK peptide on hair growth (45 men), Ann Dermatol 2016
- PubMed: Iwabuchi et al., Topical penta-peptide Gly-Pro-Ile-Gly-Ser in Japanese men with androgenetic alopecia (22 men), J Cosmet Dermatol 2016
- PubMed: Hwang et al., Low-molecular-weight collagen peptide supplementation and hair shaft diameter (114 women), J Med Food 2026
- PubMed: Najafi et al., Systematic review of GHK-Cu in topical microneedle delivery, Arch Intern Med Res 2026
- PubMed: King et al., Two phase 3 trials of baricitinib for alopecia areata, NEJM 2022
- FDA press release, June 13, 2022: FDA approves first systemic treatment for alopecia areata (archived copy)
- DailyMed (FDA label): Propecia (finasteride) prescribing information
- DailyMed (FDA label): Men's Rogaine foam (minoxidil 5%) Drug Facts
- DailyMed (FDA label): Women's Rogaine foam (minoxidil) Drug Facts
- DailyMed (FDA label): Zepbound (tirzepatide) prescribing information
- DailyMed (FDA label): Wegovy (semaglutide) prescribing information
- DailyMed (FDA label): Ozempic (semaglutide) prescribing information
- DailyMed (FDA label): Mounjaro (tirzepatide) prescribing information
- FDA: Questions and answers on dietary supplements (FDA does not approve supplements before sale)
- FDA: Understanding the risks of compounded drugs
- FDA: Concerns with unapproved GLP-1 drugs used for weight loss (28-day vial advice, warm shipments, “research” products)
- FDA: Bulk drug substances that may present significant safety risks (Category 2 and withdrawn list)